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Abstract 
Objective: E-cadherin is a classic cadherin that plays a key role in epithelial cell adhesion. This 
protein is being referred to as the suppressor of proliferation and invasion. Limited studies have 
investigated E-cadherin expression in salivary gland neoplasms. This study sought to assess the 
expression of E-cadherin and its possible role in progression and invasion of salivary gland 
neoplasms. 
Methods: In this retrospective cross-sectional study, 15 samples of pleomorphic adenoma (PA) and 
9 samples of mucoepidermoid carcinoma (MEC) were immunohistochemically stained for 
evaluation of E-cadherin expression. Degree of staining was calculated as the percentage of 
positively stained cell membranes out of a minimum of 1000 neoplastic cells.  
Results: In normal salivary gland specimens, intense membrane staining was observed around the 
acinar mucous and serous cells as well as the ductal cells. Myoepithelial cells were negative. In PA, 
intense staining was noted along the membrane of attached cells forming the ducts, islands, cellular 
cords and cellular sheets but the stromal myoepithelial cells were negative. In MEC, epidermoid and 
intermediate cells showed intense membrane staining. Mucous cells also showed membrane staining. 
After statistical analysis, the percentage of positive cells was found to be 82.56±11.66 and 67.4±7.24 
in MEC and PA, respectively. This difference was not statistically significant (P>0.05). 
Conclusion: E-cadherin expression was not a suitable marker for differentiation of PA from MEC. It 
was only correlated with cell phenotype. 
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Salivary gland tumors comprise an important 
group of oral neoplasms. Due to cellular and 
structural complexity, they show variable 
biological behavior. Various studies have been 
conducted in this respect (1) since information 
about the pathogenesis and biological behavior 
of tumors can help in accurate diagnosis and 
successful treatment (2). PA is the most common 
benign salivary gland tumor while MEC is the 
most common malignant salivary tumor (3). PA 
is comprised of epithelial and myoepithelial cells 
in a mesenchymal stroma (4). MEC contains 
epidermoid, intermediate and mucous cells 
showing a solid or cystic pattern (5). E-cadherin 
belongs to the cadherin super family. They are 
intra-membranous adhesion molecules that play 
important roles in cell adhesion, forming 
adherens junctions to bind cells within tissues 
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together.  They are also involved in tissue 
development and cell morphology (6). 
Decreased expression of E-cadherin has been 
reported in oral squamous cell carcinoma, 
odontogenic tumors, soft tissue sarcomas, 
prostate cancer, breast cancer and colorectal 
cancer by several researchers (7-12). Decreased 
E-cadherin expression has been shown to be 
associated with an invasive behavior, high 
proliferation, poor differentiation, invasion, 
metastasis and poor prognosis (13). 
The present study sought to assess the 
expression of E-cadherin marker in PA and 
MEC and its possible role in development, 




In this retrospective cross-sectional analytical 
study, 15 samples of PA and 9 samples of MEC 
were selected from the archives of the Pathology 
Department of Imam Khomeini and Jahad 
Daneshgahi hospitals in Ahvaz. All specimens 
were evaluated and confirmed by an oral 
pathologist. Specimens with inadequate sample 
size, poor quality or indefinite diagnosis were 
excluded from the study. The selected blocks 
were cut into 4 micron slices. For 
Immunohistochemical staining, E-cadherin 
marker and streptavidin biotinstandard method 
were used. Degree of staining of samples was 
then compared.   
Immunohistochemistry (IHC) 
The prepared slices were deparaffinized and 
dehydrated. For antigen stabilization, slides were 
immersed in buffered citrate solution with a pH 
of 6 and placed in a microwave for 10 min. After 
washing with phosphate buffered saline (PBS), 
the slides were incubated for an hour with E-
cadherin monoclonal antibody (Dako 
Cytomation, Denmark) to evaluate the 
expression of E-cadherin. After washing with 
PBS for 5 min, slides were immersed in Zymed 
streptavidin and incubated for 10 min. In the 
next step, the slides were subjected to DAB (3, 3 
diaminobenzidine hydrochloride) chromogenic 
reagent to produce a brown reaction product. 
After hematoxylin staining, dehydration with 
alcohol and clearing with Xylitol, samples were 
mounted on a slide. In order to ensure the 
staining technique, positive and negative 
controls were used at all phases. Oral mucosa 
specimens were considered as the positive 
control and slides without the primary antibody 
phase were considered as the negative control 
group (1).  
Microscopic evaluation 
Specimens were evaluated by two observers 
using Olympus CX21 light microscope (Tokyo, 
Japan). First, the stained areas were observed at 
40× magnification. Tumoral cells that showed 
membrane staining (regardless of the intensity of 
staining) were considered as positive cells. 
Afterwards, at 400× magnification, 1000 
neoplastic cells were counted in 10 random 
fields. Data were quantitatively analyzed and 
recorded as labeling index (LI) using the 
formula below: 
LI= 




Considering the high correlation coefficient 
between the two observers, the mean LI values 
were calculated, statistically analyzed and 
compared using SPSS version 16 software and t-





The mean age of patients with PA and MEC was 
34.6(3) and 47.78(7) yrs., respectively. The 
difference in this regard was not statistically 
significant (p>0.05). PA was more common 
among females while MEC was more prevalent 
among males. In terms of location, most cases of 
PA were in parotid gland while the majority of 
MECs were found in minor salivary glands. All 
understudy specimens including normal salivary 
gland tissue, PA and MEC tumors stained 
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positive for this marker but were different in 
terms of degree and pattern of staining. In 
evaluation of normal salivary gland tissue, 
intense membrane staining was noted in acinar 
mucous and serous cells as well as ductal cells. 
Myoepithelial cells were not stained (Figure 1). 
 
 
Figure 1- Membrane staining of acinar and ductal 
cells of normal salivary gland tissue showing E-
cadherin expression (200× magnification) 
 
In PA specimens, intense staining along the 
membrane of attached cells forming the ducts, 
islands, cellular cords and sheets was noted. But, 
the myoepithelial cells present in myxoid and 
chondroid stroma were not stained (Figure 2). 
 
 
Figure 2- Membrane staining revealing the 
expression E-cadherin marker in PA (400× 
magnification) 
 
In MEC, epidermoid and intermediate cells 
showed intense membrane staining. Occasional 
cytoplasmic or granular staining patterns were 
observed as well. Mucous cells also showed 
membrane staining (Figure 3). After the 
evaluation of slides and statistical analyses, 
percentage of positive cells in MEC and PA was 
found to be 82.56 (11.66) and 67.4 (7.24), 
respectively. The difference in this respect was 
not statistically significant (p>0.05). Degree 
(percentage) of staining of specimens was 15 to 
100%. 
 
Figure 3- Membrane staining of epidermoid cells 






Tumors arising from salivary glands are not very 
common and include a series of neoplasms with 
different cell morphology and variable 
biological behavior (14). Among them, PA is the 
most common benign salivary tumor while MEC 
is the most common malignancy (3). E-cadherin 
is a 120 KD glycoprotein involved in epithelial 
cell adhesion. Decreased expression of this 
protein and related adhesion molecules in many 
neoplasms is associated with invasion, 
metastasis, low histological grade and poor 
prognosis (13). In normal epithelial tissues, this 
protein is expressed as a membrane protein 
(6).But, its abnormal expression as acytoplasmic 
or granular protein or its lack of expression have 
been seen in some human neoplasms as well 
(15). At present, only a few studies are available 
regarding the expression of this marker in 
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benign and malignant salivary gland tumors (5). 
In our study, E-cadherin expression was 
observed in both groups of benign and malignant 
tumors as well as normal salivary gland tissue. 
These results are in accordance with many 
previous studies (1, 5, 6, 16, 17). In all 
mentioned studies, E-cadherin expression was 
observed in normal salivary gland tissue in the 
form of membrane staining around the acinar 
mucous and serous as well as ductal cells. In a 
study by Andreadis et al. in 2006 (16) decreased 
or no expression of this marker was noted in the 
PA group mostly in cells with plasmacytoid and 
stromal differentiation. However, E-cadherin 
expression was intensely positive in other benign 
tumors such as Warthin’s tumor. A mild to 
moderate decrease in E-cadherin expression was 
observed in MEC. Their obtained results 
regarding PA and MEC were similar to our 
findings. But an overall comparison between 
malignant tumors showed that decreased 
expression of this protein was associated with 
higher degree of invasion, cell phenotype and 
poor differentiation.  
According to Shieh et al. in 2003 (5), abnormal 
expression of E-cadherin occurs in the majority 
of MEC cases. In another study, of 7 MEC 
cases, 6 showed normal and one showed 
abnormal expression of this marker (18). In a 
study by Furuse et al. in 2006 (17), membrane 
expression of this marker was reported in all 
benign and malignant salivary gland tumors. In 
our study, occasional cytoplasmic and granular 
expressions were found in some cases of MEC. 
In some other studies like that of 
Economopoulou et al. in 2000 (6) the majority 
of salivary gland neoplasms regardless of their 
type, intensely expressed this marker and its 
decreased expression was seen in stromal and 
myoepithelial cells in PA. In MEC, no focal 
expression of marker was seen. Furthermore, 
increased or decreased E-cadherin expression 
was not associated with histological degree, 
differentiation or invasion in any of the 
malignant lesions. Thus, they concluded that in 
contrast to the malignant lesions in other parts of 
the body (such as colon adenocarcinoma), this 
protein is not a suitable marker for diagnosis or 
determination of prognosis of salivary tumors.  
The results of Prabhu et al. in 2009 were 
somehow different from the previous studies 
(13) because they reported lower expression of 
E-cadherin in malignant lesions compared to 
PA. They concluded that decreased expression 
of this protein occurs in differentiation of 
epithelial cells to stromal or myoepithelial 
phenotypes. Such conflicting results may be 
attributed to the microscopic pattern of PA and 
volume ratio of epithelial and myoepithelial cells 
since these tumors have very different 
microscopic patterns. In all evaluations, 
myoepithelial cells showed poor staining. 
Decreased expression of E-cadherin was also 
observed when evaluating its expression in other 
salivary gland tumors like Adenoid cystic 
carcinoma (ADCC) and comparing the primary 
tumors with recurrent and metastatic ones. Also, 
a significant association existed between gene 
methylation as well as decreased expression of 
E-cadherin and tumor progression and neural 
and vascular invasion. Furthermore, in some 
other investigations microscopic solid forms of 
this tumor showed decreased expression of this 




E-cadherin expression is not a suitable marker 
for the comparison of malignant MEC and 
benign PA. In contrast to many other malignant 
lesions, no significant correlation was found 
between malignancy of the tumor and decreased 
expression of this marker in salivary gland 
tumors. Also, this protein shows minimal 
stromal and myoepithelial staining and its 
decreased or increased expression depends on 
cell phenotype.  
The present study had low reliability due to the 
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small number of samples. Future studies with a 
larger sample size are recommended on other 
salivary gland tumors and the relationship of E-
cadherin expression with other adhesion 
molecules needs to be further investigated as 
well. 
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